View Author
study cpg b age-related macular degeneration macular mutation allele patient control stage 1.00 complement effect nk cells granulocyte signi disease netherland rotterdam degeneration effector antitumor tumor factor efficacy variant age-related association p 314l therapy expression frequency result signi ficantly population genotype receptor ophthalmology effector cells r 102g analysis depletion antibody cpg odn murine change haplotype fc ri rotterdam study ccl 2 cpg odns cancer ala 10val mutation tlr 4 gene model protein c 3 gene ccr 2 case-control study vitelliform macular dystrophy hfc ri department table 10val ficant ratio antitumor activity activity immunol dystrophy polymorphism signi ficant differences ficantly component individual vitelliform lymphoma group difference blood thr 6pro
7 Most Recent Publications
|
Daily Activities and Happiness in Later Life: The Role of Work Status
(Article)
Tadic, M. Oerlemans, W.G.M. Bakker, A. Veenhoven, R. |
2012-09-28
|
|
Simultaneous mutation detection in 90 retinal disease genes in multiple patients using a custom-designed 300-kb retinal resequencing chip
(Article)
Booij, J.C. Bakker, A. Florijn, R.J. Kulumbetova, J. Moutaoukil, Y. Smeets, B. Verheij, J.B. Kroes, H.Y. Klaver, C.C.W. Schooneveld, M.J. Bergen, A.A.B |
2011-01-01
|
|
Course of visual decline in relation to the best1 genotype in vitelliform macular dystrophy
(Article)
Booij, J.C. Boon, C.J.F. Schooneveld, M.J. Brink, J.B. ten Bakker, A. Jong, P.T.V.M. de Hoyng, C. Bergen, A.A.B Klaver, C.C.W. |
2010-07-01
|
|
Complement Component C3 and Risk of Age-Related Macular Degeneration
(Article)
Despriet, D.D.G. Duijn, C.M. van Bergen, A.A.B Klaver, C.C.W. Oostra, B.A. Uitterlinden, A.G. Hofman, A. Wright, A.F. Bakker, A. Jong, P.T.V.M.d. Brink, J.B. ten Vingerling, J.R. |
2009-01-26
|
|
Suicidal thoughts among medical residents with burnout
(Article)
Heijden, F.M.M.A. van der Dillingh, G. Bakker, A. Prins, J. |
2008-10-01
|
|
Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degeneration
(Article)
Despriet, D.D.G. Bergen, A.A.B Allikmets, R. Klaver, C.C.W. Merriam, J.E. Zernant, J. Barile, G.R. Smith, T. Barbazetto, I.A. Soest, S. van Bakker, A. Jong, P.T.V.M. de |
2008-01-01
|
|
CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations
(Article)
Ojik, H.H. van Bevaart, L. Dahle, C.E. Bakker, A. Jansen, M.J.H. Vugt, M.J. van Winkel, J.G. van de Weiner, G.J. |
2003-01-01
|
